Correlation Between Anheuser Busch and Predictive Oncology

Can any of the company-specific risk be diversified away by investing in both Anheuser Busch and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anheuser Busch and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anheuser Busch Inbev and Predictive Oncology, you can compare the effects of market volatilities on Anheuser Busch and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anheuser Busch with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anheuser Busch and Predictive Oncology.

Diversification Opportunities for Anheuser Busch and Predictive Oncology

-0.14

Correlation Coefficient

Anheuser Busch  Predictive Oncology

Good diversification

The 3 months correlation between Anheuser and Predictive is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Anheuser Busch Inbev and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and Anheuser Busch is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anheuser Busch Inbev are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of Anheuser Busch i.e., Anheuser Busch and Predictive Oncology go up and down completely randomly.

Pair Corralation between Anheuser Busch and Predictive Oncology

Considering the 90-day investment horizon Anheuser Busch Inbev is expected to generate 0.25 times more return on investment than Predictive Oncology. However, Anheuser Busch Inbev is 3.93 times less risky than Predictive Oncology. It trades about 0.08 of its potential returns per unit of risk. Predictive Oncology is currently generating about -0.02 per unit of risk. If you would invest  6,457  in Anheuser Busch Inbev on April 21, 2025 and sell it today you would earn a total of  334.00  from holding Anheuser Busch Inbev or generate 5.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Anheuser Busch Inbev  vs.  Predictive Oncology

Anheuser Busch Inbev

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Anheuser Busch Inbev are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Anheuser Busch is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Predictive Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Predictive Oncology is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Anheuser Busch and Predictive Oncology

The main advantage of trading using opposite Anheuser Busch and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anheuser Busch position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.

The idea behind Anheuser Busch Inbev and Predictive Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.